Identification and characterization of the Plasmodium vivax thrombospondin-related apical merozoite protein

Autor: Villarreal-Gonzalez Silvana, Moreno-Perez Darwin A, Angel Diana I, Mongui Alvaro, Almonacid Hannia, Vanegas Magnolia, Patarroyo Manuel A

Publikováno v: Malaria Journal, Vol 9, Iss 1, p 283 (2010)

Abstract Background Malaria caused by Plasmodium vivax is a major public health problem worldwide that affects 70-80 million people in the Middle East, Asia, Western Pacific, South America and the Caribbean. Despite its epidemiological importance, fe

Externí odkaz: https://doaj.org/article/54bc597642b840ff94d6c7f956a98e69

Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.

Autor: Sotelo-Rodríguez C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Vallejo-Ardila D; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Chamorro DF; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Rodríguez J; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Moreno-Pérez DA; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Carranza H; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Otero J; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Vargas C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Archila P; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Rojas L; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Zuluaga J; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Rubio C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia., Ordóñez-Reyes C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Garcia-Robledo JE; Hematology/Oncology Division, Mayo Clinic, Scottsdale, AZ., Mejía S; Thoracic Oncology Unit, Clínica Las Américas, Medellín, Colombia., Jaller E; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia., Arrieta O; Thoracic Oncology Unit, National Cancer Institute (INCan), México City, México., Cardona AF; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.; Direction of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2024 Jan; Vol. 10, pp. e2300011.

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.

Autor: Chamorro DF; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Cardona AF; Direction of Research, Science, and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Calle 168 # 14, 110221, Bogotá, Colombia. acardona@fctic.org.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. acardona@fctic.org., Rodríguez J; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Ruiz-Patiño A; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Arrieta O; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México City, Mexico., Moreno-Pérez DA; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Rojas L; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México City, Mexico., Zatarain-Barrón ZL; Thoracic Oncology Unit and Personalized Oncology Laboratory, National Cancer Institute (INCan), México City, Mexico., Ardila DV; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Viola L; Thoracic Oncology Unit, Fundación Neumológica Colombiana-FNC, Bogotá, Colombia., Recondo G; Thoracic Oncology Unit, Centro de Educación Médica e Investigaciones Clinicas (CEMIC), Buenos Aires, Argentina., Blaquier JB; Thoracic Oncology Unit, Centro de Educación Médica e Investigaciones Clinicas (CEMIC), Buenos Aires, Argentina., Martín C; Thoracic Oncology Unit, Alexander Fleming Institute, Buenos Aires, Argentina., Raez L; Thoracic Oncology Program, Memorial Cancer Institute, Florida Atlantic University (FAU), Miami, FL, USA., Samtani S; Medical Oncology Department, Bradford Hill Institute, Santiago, Chile., Ordóñez-Reyes C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Garcia-Robledo JE; Division of Hematology/Oncology, Mayo Clinic, Scottsdale, USA., Corrales L; Thoracic Oncology Unit, Centro de Investigación y Manejo del Cáncer-CIMCA, San José, Costa Rica., Sotelo C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Ricaurte L; Pathology Department, Mayo Clinic, Rochester, MA, USA., Cuello M; Medical Oncology Department, Hospital de Clínicas, Universidad de la Republica-UdeLAR, Montevideo, Uruguay., Mejía S; Toracic Oncology Unit, Oncology Department, Cancer Institute, Clínica de las Américas, Medellín, Colombia., Jaller E; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Vargas C; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Carranza H; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Otero J; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Archila P; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Bermudez M; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Gamez T; Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.; Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad el Bosque, Bogotá, Colombia., Russo A; Medical Oncology Department, Azienda Ospedaliera Papardo, Messina, Sicilia, Italy., Malapelle U; Predictive Molecular Pathology Laboratory, Department of Public Health, University Federico II of Naples, Naples, Italy., de Miguel Perez D; Thoracic Oncology Center, Tisch Cáncer Center, Mount Sinai Hospital System & Icahn School of Medicine, Mount Sinai, New York, NY, USA., de Lima VCC; Thoracic Oncology Unit, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Freitas H; Thoracic Oncology Unit, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Saldahna E; Thoracic Oncology Unit, A.C. Camargo Cancer Center, Sao Paulo, Brazil., Rolfo C; Thoracic Oncology Center, Tisch Cáncer Center, Mount Sinai Hospital System & Icahn School of Medicine, Mount Sinai, New York, NY, USA., Rosell R; Cancer Biology and Precision Medicine Program, Germans Trias i Pujol Research Institute (IGTP)/Dr. Rosell Oncology Institute (IOR) Quirón-Dexeus University Institute, Barcelona, Spain.

Publikováno v: Targeted oncology [Target Oncol] 2023 May; Vol. 18 (3), pp. 425-440. Date of Electronic Publication: 2023 Apr 05.

Developing Anti- Babesia bovis Blood Stage Vaccines: A New Perspective Regarding Synthetic Vaccines.

Autor: Cuy-Chaparro L; PhD Programme in Biotechnology, Sciences Faculty, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá DC 111321, Colombia.; Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá DC 111321, Colombia., Reyes C; PhD Programme in Biotechnology, Sciences Faculty, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá DC 111321, Colombia.; Structure Analysis Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá DC 111321, Colombia., Díaz-Guiot EV; Animal Science Faculty, Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Calle 222#55-37, Bogotá DC 111166, Colombia., Moreno-Pérez DA; Animal Science Faculty, Universidad de Ciencias Aplicadas y Ambientales (U.D.C.A), Calle 222#55-37, Bogotá DC 111166, Colombia., Patarroyo MA; Molecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá DC 111321, Colombia.; Microbiology Department, Faculty of Medicine, Universidad Nacional de Colombia, Carrera 45#26-85, Bogotá DC 111321, Colombia.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 09; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 09.

Identification of Multiple Blastocystis Subtypes in Domestic Animals From Colombia Using Amplicon-Based Next Generation Sequencing.

Autor: Higuera A; Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia., Herrera G; Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia., Jimenez P; Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia., García-Corredor D; Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia., Pulido-Medellín M; Grupo de Investigación en Medicina Veterinaria y Zootecnia, Facultad de Ciencias Agropecuarias, Universidad Pedagógica y Tecnológica de Colombia, Bogotá, Colombia., Bulla-Castañeda DM; Grupo de Investigación en Medicina Veterinaria y Zootecnia, Facultad de Ciencias Agropecuarias, Universidad Pedagógica y Tecnológica de Colombia, Bogotá, Colombia., Pinilla JC; Grupo de Investigación en Ciencias Agropecuarias, Facultad de Ciencias Exactas, Naturales y Agropecuarias, Universidad de Santander, Bucaramanga, Colombia., Moreno-Pérez DA; Universidad de Ciencias Aplicadas y Ambientales, Bogotá, Colombia., Maloney JG; Environmental Microbial and Food Safety Laboratory, Beltsville Agricultural Research Center (BARC), United States Department of Agriculture (USDA-ARS), Beltsville, MD, United States., Santín M; Environmental Microbial and Food Safety Laboratory, Beltsville Agricultural Research Center (BARC), United States Department of Agriculture (USDA-ARS), Beltsville, MD, United States., Ramírez JD; Centro de Investigaciones en Microbiología y Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.

Publikováno v: Frontiers in veterinary science [Front Vet Sci] 2021 Aug 24; Vol. 8, pp. 732129. Date of Electronic Publication: 2021 Aug 24 (Print Publication: 2021).